199 related articles for article (PubMed ID: 29462407)
1. Transitional changes in the incidence of osteonecrosis in systemic lupus erythematosus patients: focus on immunosuppressant agents and glucocorticoids.
Nawata K; Nakamura J; Ikeda K; Furuta S; Nakajima H; Ohtori S; Hagiwara S; Wako Y; Miura M; Kawarai Y; Sugano M; Yoshino K; Orita S; Inage K; Akazawa T
Rheumatology (Oxford); 2018 May; 57(5):844-849. PubMed ID: 29462407
[TBL] [Abstract][Full Text] [Related]
2. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study.
Shigemura T; Nakamura J; Kishida S; Harada Y; Ohtori S; Kamikawa K; Ochiai N; Takahashi K
Rheumatology (Oxford); 2011 Nov; 50(11):2023-8. PubMed ID: 21865285
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
[TBL] [Abstract][Full Text] [Related]
4. Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence.
Nakamura J; Ohtori S; Sakamoto M; Chuma A; Abe I; Shimizu K
Clin Exp Rheumatol; 2010; 28(1):13-8. PubMed ID: 20346232
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.
Ruiz-Arruza I; Ugarte A; Cabezas-Rodriguez I; Medina JA; Moran MA; Ruiz-Irastorza G
Rheumatology (Oxford); 2014 Aug; 53(8):1470-6. PubMed ID: 24681836
[TBL] [Abstract][Full Text] [Related]
6. Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus.
Tse SM; Mok CC
Lupus; 2017 Jun; 26(7):715-722. PubMed ID: 27831540
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment.
Oinuma K; Harada Y; Nawata Y; Takabayashi K; Abe I; Kamikawa K; Moriya H
Ann Rheum Dis; 2001 Dec; 60(12):1145-8. PubMed ID: 11709458
[TBL] [Abstract][Full Text] [Related]
8. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI.
Nagasawa K; Tada Y; Koarada S; Horiuchi T; Tsukamoto H; Murai K; Ueda A; Yoshizawa S; Ohta A
Lupus; 2005; 14(5):385-90. PubMed ID: 15934439
[TBL] [Abstract][Full Text] [Related]
9. Oral glucocorticoid use and osteonecrosis in children and adults with chronic inflammatory diseases: a population-based cohort study.
Horton DB; Haynes K; Denburg MR; Thacker MM; Rose CD; Putt ME; Leonard MB; Strom BL
BMJ Open; 2017 Jul; 7(7):e016788. PubMed ID: 28733303
[TBL] [Abstract][Full Text] [Related]
10. Age at time of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus: a prospective magnetic resonance imaging study.
Nakamura J; Saisu T; Yamashita K; Suzuki C; Kamegaya M; Takahashi K
Arthritis Rheum; 2010 Feb; 62(2):609-15. PubMed ID: 20112393
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis.
Krez A; Lane J; Heilbronner A; Park-Min KH; Kaneko K; Pannellini T; Mintz D; Hansen D; McMahon DJ; Kirou KA; Roboz G; Desai P; Bockman RS; Stein EM
Osteoporos Int; 2021 Oct; 32(10):2095-2103. PubMed ID: 33877383
[TBL] [Abstract][Full Text] [Related]
12. Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study.
Touma Z; Sayani A; Pineau CA; Fortin I; Matsos M; Ecker GA; Chow A; Iczkovitz S
Rheumatol Int; 2017 Jun; 37(6):865-873. PubMed ID: 28280970
[TBL] [Abstract][Full Text] [Related]
13. Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study.
Long Y; Zhang S; Zhao J; You H; Zhang L; Li J; Leng X; Wang Q; Tian X; Li M; Zeng X
Lupus; 2021 Aug; 30(9):1459-1468. PubMed ID: 34082592
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of incidence and clinical characteristics of osteonecrosis of femoral head in patients with systemic lupus erythematosus treated with glucocorticoid: A descriptive study based on a prospective cohort].
Xu Y; Chen S; Cai Q; Zhang C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2023 May; 37(5):605-614. PubMed ID: 37190840
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging-detected avascular osteonecrosis in systemic lupus erythematosus: lack of correlation with antiphospholipid antibodies.
Houssiau FA; N'Zeusseu Toukap A; Depresseux G; Maldague BE; Malghem J; Devogelaer JP; Vande Berg BC
Br J Rheumatol; 1998 Apr; 37(4):448-53. PubMed ID: 9619898
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced osteonecrosis in systemic lupus erythematosus patients.
Kaneko K; Chen H; Kaufman M; Sverdlov I; Stein EM; Park-Min KH
Clin Transl Med; 2021 Oct; 11(10):e526. PubMed ID: 34709753
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic osteonecrosis of the hip and knee after cardiac transplantation.
Lieberman JR; Roth KM; Elsissy P; Dorey FJ; Kobashigawa JA
J Arthroplasty; 2008 Jan; 23(1):90-6. PubMed ID: 18165036
[TBL] [Abstract][Full Text] [Related]
18. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.
Fialho SC; Bonfá E; Vitule LF; D'Amico E; Caparbo V; Gualandro S; Pereira RM
Lupus; 2007; 16(4):239-44. PubMed ID: 17439929
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy.
Ha Y; Lee KH; Jung S; Lee SW; Lee SK; Park YB
Lupus; 2011 Oct; 20(10):1027-34. PubMed ID: 21659423
[TBL] [Abstract][Full Text] [Related]
20. Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study.
Ruiz-Arruza I; Lozano J; Cabezas-Rodriguez I; Medina JA; Ugarte A; Erdozain JG; Ruiz-Irastorza G
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):582-591. PubMed ID: 28704598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
